Genitourinary melanoma accounts for 0.1-0.2% of melanoma, the scrotum being its rarest location. We report about an 85-year-old patient who was referred to our outpatient clinic due to the presence of a scrotum black papule for 20 months. Wide local excision was performed, and histology revealed a malignant melanoma. Chest and abdominal CT revealed metastatic disease, so chemotherapy, immunotherapy and radiotherapy were administered. We describe the evolution over 1 year in this unusual location, as well as complications and the currently available therapeutic options to cure this disease.

Keywords:
Chemotherapy, Melanoma, Molecular targeted therapy, Radiotherapy, Scrotum
1.
Sanchez A, Rodríguez D, Allard CB, Bechis SK, Sullivan RJ, Boeke CE, Kuppermann D, Cheng JS, Barrisford GW, Preston MA, Feldman AS: Primary genitourinary melanoma: epidemiology and disease-specific survival in a large population-based cohort. Urol Oncol 2016;34:166.e7-e14.
2.
Buzaid AC, Gershenwald JE, Atkins MB, Ross ME: Tumor node metastasis (TNM) staging system and other prognostic factors in cutaneous melanoma. http://www.uptodate.com (accessed June 24, 2015).
3.
Ríos L, Nagore E, López JL, Redondo P, Martí RM, Fernández-de-misa R, Soler B: Melanoma characteristics at diagnosis from the Spanish National Cutaneous Melanoma Registry: 15 years of experience. Actas Dermosifiliogr 2013;104:789-799.
4.
Sánchez-Ortiz R, Huang SF, Tamboli P, Prieto VG, Hester G, Pettaway CA: Melanoma of the penis, scrotum and male urethra: a 40-year single institution experience. J Urol 2005;173:1958-1965.
5.
Ranjan A, Mukta K: A malignant transformation in a pre-existing bening scrotal naevus. J Clin Diagn Res 2012;6:1562-1563.
6.
Vasudeva P, Agrawal D, Goel A: Malignant melanoma of the scrotum. Urology 2008;71:1053-1054.
7.
Zuluaga-Sepúlveda MA, Arellano-Mendoza I, Ocampo-Candiani J: [Update on surgical treatment of primary and metastatic cutaneous melanoma]. Cir Cir 2016;84:77-84.
8.
Dummer R, Hauschild A, Lindenblatt N, Pentheroudakis G, Keilholz U; ESMO Guidelines Committee: Cutaneous melanoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2015;26(suppl 5):v126-v132.
9.
Luke JJ, Ott PA: New developments in the treatment of metastatic melanoma - role of dabrafenib-trametinib combination therapy. Drug Healthc Patient Saf 2014;6:77-88.
10.
Filippi AR, Fava P, Badellino S, Astrua C, Ricardi U, Quaglino P: Radiotherapy and immune checkpoints inhibitors for advanced melanoma. Radiother Oncol 2016;120:1-12.
11.
Damala K, Tsanou E, Pappa L, Sintou-Mantela E, Peschos D, Agnantis N, Malamou-Mitsi V: A rare case of primary malignant melanoma of the scrotum diagnosed by fine-needle aspiration. Diagn Cytopathol 2004;31:413-416.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.